Interleukin-6 (IL-6) is a pivotal cytokine in inflammation-associated liver disease, and the current evidence suggested it has both pro-inflammation and anti-inflammation effects where IL-6 released from adiposity can promote inflammation and muscle-derived IL-6 can ameliorate inflammation (Giraldez et al., 2021). The gene discussed is IL6; the disease is liver disorder.